Current status of carbapenemases in Latin America
- PMID: 23879607
- DOI: 10.1586/14787210.2013.811924
Current status of carbapenemases in Latin America
Abstract
Enterobacteriaceae and non fermenting Gram-negative bacilli have become a threat to public health, in part due to their resistance to multiple antibiotic classes, which ultimately have led to an increase in morbidity and mortality. β-lactams are currently the mainstay for combating infections caused by these microorganisms, and β-lactamases are the major mechanism of resistance to this class of antibiotics. Within the β-lactamases, carbapenemases pose one of the gravest threats, as they compromise one of our most potent lines of defense, the carbapenems. Carbapenemases are being continuously identified worldwide; and in Latin America, numerous members of these enzymes have been reported. In this region, the high incidence of reports implies that carbapenemases have become a menace and that they are an issue that must be carefully studied and analyzed.
Comment in
-
New carbapenases in Brazil.Expert Rev Anti Infect Ther. 2014 Feb;12(2):155-6. doi: 10.1586/14787210.2014.867804. Epub 2013 Dec 11. Expert Rev Anti Infect Ther. 2014. PMID: 24325641 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources